|
Real-time Estimate
Cboe BZX
12:24:15 30/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 7.925 USD | -0.69% |
|
+1.01% | +19.62% |
| 12/08 | Harvard Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 11/08 | Harvard Bioscience, Inc., Q2 2026 Earnings Call, Aug 11, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.69% | +1.01% | -1.36% | +30.61% | +19.62% | +81.90% | -81.40% | -88.57% | -70.80% | 36.33M | ||
| -1.00% | +2.15% | +9.01% | +32.84% | +16.09% | +45.60% | +32.90% | +16.06% | +331.06% | 251B | ||
| -1.58% | +1.39% | +4.97% | +16.28% | -2.07% | +20.48% | -9.65% | -26.89% | +190.64% | 160B | ||
| -1.38% | +1.99% | +8.81% | +1.01% | -27.59% | -6.64% | +40.30% | +23.97% | +412.60% | 147B | ||
| -1.54% | -3.12% | -9.90% | +0.09% | -54.36% | -55.15% | -17.58% | -0.84% | +86.78% | 63.93B | ||
| -0.37% | -2.26% | -4.38% | -4.83% | +1.79% | +12.42% | +25.25% | -23.56% | +118.28% | 50.05B | ||
| -0.60% | +4.11% | +13.40% | +31.09% | +27.97% | +40.71% | +55.72% | +8.83% | +275.20% | 49.4B | ||
| -0.19% | +3.07% | -1.41% | +13.27% | -14.11% | -15.39% | -19.62% | -30.71% | - | 48.94B | ||
| -0.75% | +3.28% | +6.05% | +19.20% | +15.76% | +51.92% | +60.35% | +20.41% | +181.25% | 43.52B | ||
| -1.57% | +8.67% | +25.88% | +48.49% | +105.03% | +192.72% | +95.89% | -34.67% | +52.31% | 41.06B | ||
| -0.56% | -0.29% | -7.82% | +11.54% | -8.11% | -18.34% | +49.68% | -16.59% | +244.70% | 31.77B | ||
| -1.15% | -0.16% | -7.11% | +1.71% | -19.33% | -9.47% | -2.76% | - | - | 30.16B | ||
| +0.45% | +0.61% | -3.22% | +18.68% | -16.51% | -33.34% | -41.07% | -58.16% | - | 28.51B | ||
| -1.18% | -0.64% | -5.24% | -8.90% | -6.58% | -5.65% | +18.38% | -39.90% | -9.13% | 24.42B | ||
| -0.97% | +4.49% | +16.38% | +34.65% | +54.77% | +77.84% | +35.27% | -14.46% | +171.56% | 16.85B | ||
| +0.32% | +1.07% | -5.70% | +20.34% | +2.12% | +7.65% | +2.66% | -17.57% | +131.93% | 13.64B | ||
| -0.03% | +3.29% | +8.99% | +5.89% | +34.21% | +104.74% | +1.48% | -20.04% | +182.51% | 9.64B | ||
| -2.80% | -0.37% | +13.65% | +50.90% | +19.88% | +8.55% | -2.72% | - | - | 4.47B | ||
| -0.04% | +0.00% | +0.87% | +38.49% | +61.08% | +24.94% | +61.08% | +38.77% | +494.52% | 4.3B | ||
| +3.20% | -7.12% | +3.82% | +16.89% | -16.60% | -35.12% | - | - | - | 4.19B | ||
| Average | -0.61% | +2.06% | +3.28% | +18.91% | +9.65% | +24.52% | +16.01% | -15.52% | +186.23% | 51.11B | |
| Weighted average by Cap. | -1.00% | +3.62% | +4.99% | +17.49% | +2.01% | +22.24% | +22.38% | -3.32% | +248.62% |
- Stock Market
- Stocks
- HBIO Stock
- Sector Harvard Bioscience, Inc.
Select your edition
All financial news and data tailored to specific country editions
















